Four PANoptosis-related predictors (MYBL2, TUBA1C, C21orf62 and KCNIP2) were identified and predictive PANRG score model was developed for glioma based on bulk-seq and scRNA-seq analysis, which is significantly associated with tumor immune landscape and therapeutic responses. Here, KCNIP2 is linked to glioma.